Site search

Filgotinib for moderately to severely active Crohn’s disease Research study

This trial aimed to evaluate the efficacy and safety of Filgotinib in the induction and maintenance of remission in people with moderately to severely active Crohn’s disease.

Professor Bruce Campbell awarded the prestigious Woodward Medal in Science and Technology News article

Professor Bruce Campbell, Head of stroke and Interim Head of Neurology at the Royal Melbourne Hospital has been awarded the Woodward Medal in Science and Technology from the University of Melbourne.

Spesolimab for the treatment of hidradenitis suppurativa Research study

A study to measure how safe and effective spesolimab (the study drug) is in treating participants with moderate to severe hidradenitis suppurativa (HS).

Supporting cast: Family, friends and your treating team News article

We all need someone to lean on, so make the most of your supporting cast. Family, friends, treating team, carers, support groups, consumer and carer organisations can all offer ongoing and invaluable help, focus and direction to aid your recovery.

Access to the RMH Royal Park

All clinical and patient areas at the RMH Royal Park are accessible for people with disabilities.

Sponsor Office

The Office for Research Sponsor Office acts in the capacity of study sponsor on behalf of Royal Melbourne Hospital (RMH) for regulatory and legal purposes.

Breaking down barriers to palliative care News article

More patients across Victoria with sarcoma, lung and colon cancer, including in regional areas, will have the opportunity to access high quality palliative care at an earlier stage under the VCCC Alliance’s Victorian government-funded Care Plus Extend program.

Global study could change how children with multiple sclerosis are treated News article

Dr Sifat Sharmin hopes her research will influence how children with MS are treated.

TB services for healthcare professionals

The Victorian Tuberculosis Program team is an educational resource available for consultation with health professionals about TB and contact management.

New potential treatment for adult males with Tourette Syndrome Research study

A study to evaluate the safety and efficacy of new drug in male patients aged 18 to 50 with Tourette Syndrome (TS).

Rapid COVID test evaluated at the Royal Melbourne Hospital News article

Research by the Royal Melbourne Hospital (RMH) and the Peter Doherty Institute for Infectious Diseases and Immunity, published results for the validation study of rapid point-of-care antigen testing in the Lancet Regional Health Western Pacific.

Current vacancies

Find your new career at the Royal Melbourne Hospital (RMH).

Study to understand risk of Alzheimer’s disease in middle-aged adults Research study

An Australian-first online study of psychological, lifestyle and genetic factors that increase risk of Alzheimer’s disease.

The RMH and Doherty Institute staff to tackle strongyloidiasis News article

A multidisciplinary team of experts, including the RMH clinicians and the Doherty Institute researchers Professor Beverley-Ann Biggs, Associate Professor (Hon.) Siddhartha Mahanty and Dr Stephen Muhi, has secured a $5 million Synergy Grant from the National Health and Medical Research Council...

The RMH researcher receives NHMRC grant for aged care infection prevention initiative News article

Congratulations to the RMH and the University of Melbourne Researcher Dr Jo Tropea, who has received a $990,731.50 NHMRC grant to establish national communities of practice for infection prevention leads in aged care.

Business development

The Royal Melbourne Hospital, where innovation meets compassionate care. As a leader in healthcare excellence, we are dedicated to advancing medical services and fostering strategic partnerships. 

Virtual Hospital RMH Service

The Virtual Hospital Pilot uses digital technology such as video, phone and remote monitoring devices to deliver hospital-level specialist care to patients in their homes or in their local and regional hospitals.

Joint venture partners The Doherty Institute celebrates 10 years News article

Festivities for the Doherty’s 10-year anniversary are in full-swing this week, with a special event kicking off celebrations at Parliament House.

Geographic atrophy from age-related macular degeneration Research study

The Golden trial is a study of a potential new treatment referred to as ISIS 696844 to determine its safety and effectiveness in slowing the progression of geographic atrophy (GA) caused by age-related macular degeneration (AMD).

Contact Mental Health

Find out the main contact and location information for Mental Health & Wellbeing.